Virtu KCG Holdings’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.33M Sell
18,789
-39,974
-68% -$2.66M 0.04% 418
2017
Q1
$3.99M Sell
58,763
-5,545
-9% -$390K 0.11% 93
2016
Q4
$4.61M Buy
64,308
+38,750
+152% +$2.88M 0.11% 79
2016
Q3
$2.02M Buy
+25,558
New +$2.08M 0.05% 294
2016
Q2
Sell
-18,129
Closed -$1.67M 3081
2016
Q1
$1.67M Sell
18,129
-65,291
-78% -$5.89M 0.05% 345
2015
Q4
$8.44M Buy
83,420
+1,257
+2% +$131K 0.14% 73
2015
Q3
$8.07M Buy
82,163
+17,721
+27% +$1.97M 0.13% 81
2015
Q2
$7.54M Sell
64,442
-65,022
-50% -$7.1M 0.13% 72
2015
Q1
$12.7M Buy
129,464
+30,730
+31% +$3.12M 0.26% 38
2014
Q4
$9.31M Buy
98,734
+36,542
+59% +$3.78M 0.15% 58
2014
Q3
$6.62M Sell
62,192
-5,205
-8% -$510K 0.13% 96
2014
Q2
$5.59M Sell
67,397
-109,516
-62% -$8.52M 0.09% 150
2014
Q1
$12.5M Buy
176,913
+122,882
+227% +$9.64M 0.16% 80
2013
Q4
$4.06M Buy
54,031
+14,773
+38% +$1.03M 0.04% 321
2013
Q3
$2.47M Buy
+39,258
New +$2.35M 0.03% 505

Other funds holding GILD

Virtu KCG Holdings's GILD Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Gilead Sciences (GILD) stake by 68% in Q2 2017, selling an estimated $2.66M and leaving 18,789 shares worth $1.33M. The position accounts for 0.04% of the portfolio, ranked #418.

Virtu KCG Holdings first reported a position in GILD in Q3 2013 and has held it in 15 quarters since. The position peaked at $12.7M in Q1 2015. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Virtu KCG Holdings held 18,789 shares of Gilead Sciences worth $1.33M as of Q2 2017.
  • Virtu KCG Holdings sold 39,974 Gilead Sciences shares in Q2 2017, an estimated $2.66M.
  • Gilead Sciences made up 0.04% of Virtu KCG Holdings's portfolio in Q2 2017, its #418 holding.
  • Virtu KCG Holdings first reported a position in Gilead Sciences in Q3 2013 and has held it in 15 quarters since.
  • Virtu KCG Holdings's Gilead Sciences position peaked at $12.7M in Q1 2015.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.